Telomerase activity, as well as the expression of the catalytic subunit of the telomerase complex, telomerase reverse transcriptase (TERT), have been observed in most malignant BC, being considered attractive biomarkers for BC diagnosis and prognosis [15–17]. The gene discussed is TERT; the disease is breast cancer.